Global Remote Patient Monitoring Market Set to Grow Rapidly

SHERIDAN, Wyo., Sept. 18, 2026 /CourierPR/ -- The global remote patient monitoring market is poised to witness significant growth, expanding from $34.5 billion in 2026 to $62.2 billion by 2031, according to a new study by Wissen Research. This growth is projected to register a Compound Annual Growth Rate (CAGR) of 12.5% over the forecast period.

The market's expansion is driven by several factors, including the rising prevalence of chronic diseases, the growing hospital-at-home programs, and the increasing reliance on reimbursement-supported remote monitoring to reduce costly hospital readmissions. Wissen Research highlights that the most significant shift in the remote patient monitoring landscape is the move from simple data collection to active clinical decision support. AI-enabled monitoring platforms are now capable of automatically flagging abnormal vital sign trends, prioritizing alerts based on patient risk levels, and supporting predictive analytics that can anticipate disease progression, medication non-compliance, or readmission risk before a crisis occurs.

Hospital-at-home care models are a key driver of this growth. These models allow patients recovering from surgery or managing conditions like heart failure or COPD to receive acute-level care in their own homes, monitored continuously through connected diagnostic devices and wearable sensors. The availability of cellular-enabled, plug-and-play devices is also accelerating adoption, as elderly and non-technical patients no longer need a complex home network setup to be enrolled in a monitoring program.

Expanding reimbursement support, hospital readmission reduction, and the adoption of value-based care models are also contributing to the market's growth. Dedicated CMS billing codes for remote monitoring are providing providers with a direct, recurring revenue incentive to adopt RPM at scale. Health systems are deploying RPM to avoid costly 30-day readmission penalties tied to chronic disease relapse, and growing hospital-at-home programs are driving demand for continuous, connected monitoring devices that keep patients safe while recovering outside inpatient settings.

Despite the strong growth, the remote patient monitoring market continues to face operational challenges. Data protection, cybersecurity, and secure transmission of patient information remain critical concerns for healthcare facilities relying on cloud-based monitoring platforms. Integrating RPM systems with existing hospital IT and electronic health record workflows continues to pose implementation challenges. Patient adherence to monitoring programs, particularly among older adults, remains inconsistent, and device interoperability across multiple vendors adds further complexity.

Billing oversight is emerging as a growing concern, with the U.S. Department of Health and Human Services' Office of Inspector General intensifying scrutiny of RPM-related billing amid rising incidence of fraudulent claims. Alert fatigue is another persistent issue, as RPM systems scale to larger patient populations, clinical staff can be overwhelmed by high volumes of critical, non-critical, and redundant alerts, undermining the efficiency gains the technology is meant to deliver.

Leading companies in the remote patient monitoring market, including Koninklijke Philips N.V., Medtronic, GE Healthcare, Siemens Healthineers AG, and Omron Healthcare, are investing heavily in cardiac monitoring specifically, alongside a parallel push to standardize device interoperability across healthcare IT systems. Addressing one of the sector's most persistent operational bottlenecks, these efforts aim to streamline the integration of RPM devices with existing healthcare infrastructure.

In May 2026, Koninklijke Philips N.V., together with Cuviva AB and Vingmed AB, was selected by Region Stockholm to deploy a large-scale hospital-at-home remote patient monitoring program supporting continuous virtual care for up to 15,000 patients annually. In February 2026, Abbott Laboratories received U.S. FDA approval for its next-generation CardioMEMS HERO remote heart failure monitoring reader, adding improved portability and integrated cellular connectivity for real-time pulmonary artery pressure monitoring. Also in February 2026, Oracle Corporation launched the Oracle Health Device Validation Program to standardize medical device integration across healthcare systems, partnering with Bio IntelliSense and Baxter International to enable secure, scalable remote monitoring connectivity.

In October 2025, OMRON Healthcare acquired the Heartnote long-term Holter ECG analysis business from JSR Corporation, strengthening its remote cardiac monitoring capabilities across homecare and clinical settings in Japan. These strategic developments underscore the industry's focus on innovation, strategic partnerships, and expansion of health-centric connected device and software features to strengthen their market position.